Intellia Therapeutics, Inc. · NASDAQ:NTLA

Goldman Sachs Group Inc reported a 5.10% stake in Intellia Therapeutics, Inc. (Schedule 13G)

Event Sep 30, 2025 · Filed Nov 12, 2025

Goldman Sachs Group Inc reported a 5.10% stake in Intellia Therapeutics, Inc., 5,498,262 shares, as a passive investor on Sep 30, 2025. Filed Nov 12, 2025 (Schedule 13G).

Stake
5.10%
Shares
5,498,262
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
THE GOLDMAN SACHS GROUP, INC.5.10%5,498,262
GOLDMAN SACHS & CO. LLC5.10%5,498,262

Source

View original at SEC

Related